Pınar Yalçın Bahat

Dr. Pınar Yalçın Bahat

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2022
Verified
Journal Article
Open access
PBPınar Yalçın Bahat
Pınar Yalçın Bahat
IAIsil Ayhan
Isil Ayhan
EOEda Ureyen Ozdemir
Eda Ureyen Ozdemir
ÜIÜmit Inceboz
Ümit Inceboz
EOEngin Oral
Engin Oral
As search for optimal therapy continues for endometriosis, aid of dietary supplements is gaining attention. Supplements can be used for their anti-inflammatory, anti-oxidant, anti-proliferative and immune modulatory charactheristics. We reviewed the literature, evaluated and synthesized effects of vitamin D, zinc, magnesium, omega 3, propolis, quercetin, curcumin, N-acetylcysteine, probiotics, resveratrol, alpha lipoic acid, vitamin C, vitamin E, selenium and epigallocatechin-3-gallate. Based on results of in vitro, animal and human studies, it might be safe to say that dietary supplements can be used as a complementary treatment for endometriosis.

1 September 2020 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
PDF file
PBPınar Yalçın Bahat
Pınar Yalçın Bahat
CKCihan Kaya
Cihan Kaya
NSNura F.T. Selçuki
Nura F.T. Selçuki
IPİbrahim Polat
İbrahim Polat
TUTaner Usta
Taner Usta
EOEngin Oral
Engin Oral

11 August 2020 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
PDF file
PBPınar Yalçın Bahat
Pınar Yalçın Bahat
MTMerve Aldıkaçtıoğlu Talmaç
Merve Aldıkaçtıoğlu Talmaç
ABAyşegül Bestel
Ayşegül Bestel
NSNura F. Topbas Selcuki
Nura F. Topbas Selcuki
OKOzan Karadeniz
Ozan Karadeniz
IPIbrahim Polat
Ibrahim Polat

11 July 2019 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
PBPınar Yalçın Bahat
Pınar Yalçın Bahat
GTGökçe Turan
Gökçe Turan
BÖBahar Yüksel Özgör
Bahar Yüksel Özgör
KÇKübra Bağcı Çakmak
Kübra Bağcı Çakmak
Objective: In this study, we aimed to compare the seroprevalence of hepatitis B (HBV), hepatitis C (HCV), and human immunodeficieney viruse (HIV) in Syrian pregnant women and Turkish pregnant women in our hospital. Materials and Methods: In our study, a total of 68,169 Turkish pregnant women who received HB surface antigen (HBsAg), HB surface antibody (anti-HBs), HCV antibody (anti-HCV), anti-HIV test, and a total of 11,015 Syrian pregnant patients who received HBsAg, anti-HBs, anti-HCV and anti-HIV tests were examined retrospectively between January 2012 and January-2018 in Universty of Health Sciences Kanuni Sultan Suleyman Training and Research Hospital, Obstetrics and Gynecology Clinic. Results: In our study, the rates of HBsAg, anti-HCV, and anti-HIV seropositivity were 1.1%, 0.1%, and 0.03% in Syrian pregnant women between 2012 and 2018, respectively. In the other study group, in Turkish pregnant women, HBsAg, anti-HCV, and anti-HIV seropositivity rates for 2012 and 2018 were found as 1.8%, 0.2%, and 0.08%, respectively. Conclusion: Although there were no significant differences between the HBsAg, anti-HCV, and anti-HIV results of both groups, the anti-HBs positivity was higher at a significant level in Turkish pregnant women. The reason of the significantly higher anti-HBs positivity levels in pregnant women might stem from the fact that women are vaccinated and controlled regularly due to the policies in this regard in our country.

28 September 2021 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
PBPınar Yalçın Bahat
Pınar Yalçın Bahat
BYBurak Yücel
Burak Yücel
BOBahar Yuksel Ozgor
Bahar Yuksel Ozgor
PKPınar Kadiroğulları
Pınar Kadiroğulları
NSNura Fitnat Topbas Selçuki
Nura Fitnat Topbas Selçuki
EÖEda Üreyen Özdemir
Eda Üreyen Özdemir
Endometriosis is an oestrogen-dependent chronic disease, which is commonly regarded as a disease of reproductive-aged women. We aimed to evaluate the sexual function with Female Sexual Function Index (FSFI) in women with endometriosis who received dydrogesterone for 6 months. A total of 79 women with endometriomas were recruited in the study group and received 10 mg dydrogesterone tablets orally for 6 months. FSFI and visual analog scale (VAS) scores for each patient before and after treatment were recorded. When before treatment VAS scores and after treatment VAS scores (5.7 ± 1.27, 3.97 ± 1.01, respectively) were compared, a significant decrease was observed (p = .001). A significant increase in mean orgasm scores (3.23 ± 0.6 vs. 3.57 ± 0.65, p = .01) and means satisfaction scores (3.85 ± 0.48 vs. 4.10 ± 0.38, p < .001) were observed. In addition, means desire scores were also significantly higher following treatment (p = .01). In conclusion, this study showed that FSFI scores were increased after 6 months of dydrogesterone treatment in patients with endometriosis. Desire, satisfaction, orgasm and pain scores improved significantly, and sexual dysfunction decreased after treatment.

11 August 2021 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
PKPinar Kadirogullari
Pinar Kadirogullari
KSKerem Doga Seckin
Kerem Doga Seckin
PBPınar Yalçın Bahat
Pınar Yalçın Bahat
ZAZubeyde Aytufan
Zubeyde Aytufan
We aimed to investigate the efficacy of chewing gum on bowel movements after minimally invasive gynaecologic surgery, total laparoscopic hysterectomy (TLH). The study was designed as a prospective randomised controlled study. We divided the patients into two groups regarding postoperative chewing gum after elective TLH operation. The demographic status and characteristics of the patients as well as, anaesthesia and operation records were obtained. The study group was asked to chew gum for 15 min in an hour starting from post-operative 4th hour until the patient passed flatus. In each patient, first auscultation of bowel sounds, first flatus and first defaecation time, as well as first mobilisation time and discharge time, were recorded. We compared the difference in abdominal distension, nausea and vomiting and post-operative ileus (POI) rates. Eight patients were excluded from the study due to matching with exclusion criteria. The remaining 126 patients were divided into two groups. First bowel sounds, first bowel movements, the timing of first gas discharge and the timing of the first defaecation was found significantly earlier in the given-chewing gum group (p < .001). The timing of patient discharge and POI were found to be similar in each group (p > .05). Mild symptoms of ileus were observed in two patients (3.2%) in the not given-chewing gum group and three patients (5.5%) in the given-chewing gum group. The symptoms were better tolerated by the patients who chew gums and no side effects regarding the treatment were observed. In post-operative patient care after minimally invasive surgery, chewing gum has a beneficial effect on bowel movements. This inexpensive and well-tolerated procedure ameliorates gastrointestinal (GI) functions, whereas it has little benefit on early mobilisation and timing of the patient discharge after patients undergoing TLH.